Genentech’s Strategic Pivot: The Closure of Its Cancer Immunology Unit
Introduction In a significant and somewhat unexpected move within the biotech industry, Genentech, a subsidiary of Roche, has…
Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory…